Search Within

Mark Kris

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (44)
  2. Meeting Abstract (28)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (73)
  2. Sloan Kettering Institute Postdocs (73)
  3. Solid Tumor Oncology Division (73)
  4. Thoracic Oncology (73)
  5. Department of Pathology and Laboratory Medicine (63)
  6. GSK Faculty (61)

More Groups

People
  1. Gregory Riely (45)
  2. Marc Ladanyi (44)
  3. Charles Rudin (36)
  4. Alexander Drilon (30)
  5. Helena Yu (30)
  6. Maria Arcila (30)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (12)
  4. 2022 (4)
  5. 2021 (2)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Clinical Cancer Research (14)
  3. Journal of Thoracic Oncology (14)
  4. Annals of Oncology (3)
  5. Cancer Discovery (3)
  6. JCO Precision Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (18)
  3. Elsevier Inc. (15)
  4. Nature Publishing Group (5)
  5. Oxford University Press (4)
  6. Mosby Elsevier (2)

More Publishers

Results (73)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes after radiation for oligoprogressive disease sites in patients with EGFR-mutant lung cancer treated with osimertinib
    Journal Article

    Chen, M. F.; Jeng, M. Y.; Ma, J.; Agrawal, P.; Dunne, E.; Boe, L. A.; Kris, M. G.; Huang, J.; Veeraraghavan, H.; Gomez, D.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Annotated test-retest dataset of lung cancer CT scan images reconstructed at multiple imaging parameters
    Journal Article

    Zhao, B.; Dercle, L.; Yang, H.; Riely, G. J.; Kris, M. G.; Schwartz, L. H.
    Scientific Data (2024)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas: Results of a prospective pilot study
    Meeting Abstract

    Offin, M.; Lavin, Y.; Zatzman, M.; Sauter, J. L.; Ceglia, N.; Travis, W. D.; Aly, R. G.; Rimner, A.; Shepherd, A.; Simone, C. B. 2nd; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Osimertinib, platinum, etoposide as initial treatment for patients with EGFR mutant lung cancers with TP53 and RB1 alterations
    Meeting Abstract

    Chen, M. F.; Rakhade, S.; Quintanal-Villalonga, A.; Lee, J.; Forsythe, B.; Moses, K. A.; Ahn, L. S. H.; Pupo, A.; Falcon, C. J.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
    Journal Article

    Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Genomics of early progression on selpercatinib in patients with RET fusion-positive lung cancers
    Meeting Abstract

    Chen, M. F.; Rosen, E.; Falcon, C.; Repetto, M.; Yang, S. R.; Chang, J.; Kris, M. G.; Rekhtman, N.; Donoghue, M.; Drilon, A.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer
    Journal Article

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save